Fig. 2From: Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancerIHC staining of HFGs by anti-HFG mAb in tumor tissues of two patients with CRC. Positive signals are observed mainly in the cell membrane (a, red arrow, patient-19) and in cytoplasm (b, blue arrow, patient-5) of tumor cells. CRC colorectal cancer, HFG heavily fucosylated glycan, IHC immunohistochemistryBack to article page